Breast Cancer 1 MRI for breast cancer screening, diagnosis, and treatment

被引:297
作者
Morrow, Monica [1 ]
Waters, Janet [2 ]
Morris, Elizabeth [3 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Serv, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Med Lib, New York, NY 10065 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA
关键词
SURGICAL ADJUVANT BREAST; HIGH FAMILIAL RISK; CONTRALATERAL BREAST; NEOADJUVANT CHEMOTHERAPY; PREOPERATIVE MRI; TUMOR RESPONSE; CONSERVING SURGERY; ESTROGEN-RECEPTOR; MUTATION CARRIERS; WOMEN;
D O I
10.1016/S0140-6736(11)61350-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
MRI is used widely both for screening women who are at increased risk of breast cancer and for treatment selection. Prospective studies confirm that MRI screening of women with known or suspected genetic mutation results in a higher sensitivity for cancer detection than does mammography. However, survival data are not available. In women with breast cancer, MRI detects cancer not identified with other types of screening. In two randomised trials, this increased sensitivity did not translate into improved selection of surgical treatment or a reduction in the number of operations. Data for longer-term outcomes such as ipsilateral breast tumour recurrence rates and contralateral breast cancer incidence are scarce, but to date do not show clear benefit for MRI. MRI is better than other methods of assessing the response to neoadjuvant chemotherapy, and is helpful in identifying the primary tumour in patients who present with axillary adenopathy.
引用
收藏
页码:1804 / 1811
页数:8
相关论文
共 61 条
  • [51] Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia
    Port, Elisa Rush
    Park, Anna
    Borgen, Patrick I.
    Morris, Elizabeth
    Montgomery, Leslie L.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (03) : 1051 - 1057
  • [52] Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts using the whole-breast pathologic examination as a gold standard
    Sardanelli, F
    Giuseppetti, GM
    Panizza, P
    Bazzocchi, M
    Fausto, A
    Simonetti, G
    Lattanzio, V
    Del Maschio, A
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2004, 183 (04) : 1149 - 1157
  • [53] American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography
    Saslow, Debbie
    Boetes, Carla
    Burke, Wylie
    Harms, Steven
    Leach, Martin O.
    Lehman, Constance D.
    Morris, Elizabeth
    Pisano, Etta
    Schnall, Mitchell
    Sener, Stephen
    Smith, Robert A.
    Warner, Ellen
    Yaffe, Martin
    Andrews, Kimberly S.
    Russell, Christy A.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2007, 57 (02) : 75 - 89
  • [54] Does MRI predict pathologioc tumor response in women with breast cancer undergoing preoperative chemotherapy?
    Segara, Davendra
    Krop, Ian E.
    Garber, Judy E.
    Winer, Eric
    Harris, Lyndsay
    Bellon, Jennifer R.
    Birdwell, Robyn
    Lester, Susan
    Lipsitz, Stuart
    Iglehart, J. Dirk
    Golshan, Mehra
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2007, 96 (06) : 474 - 480
  • [55] Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ
    Solin, Lawrence J.
    Orel, Susan G.
    Hwang, Wei-Ting
    Harris, Eleanor E.
    Schnall, Mitchell D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (03) : 386 - 391
  • [56] Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial
    Turnbull, Lindsay
    Brown, Sarah
    Harvey, Ian
    Olivier, Catherine
    Drew, Phil
    Napp, Vicky
    Hanby, Andrew
    Brown, Julia
    [J]. LANCET, 2010, 375 (9714) : 563 - 571
  • [57] Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination
    Warner, E
    Plewes, DB
    Hill, KA
    Causer, PA
    Zubovits, JT
    Jong, RA
    Cutrara, MR
    DeBoer, G
    Yaffe, MJ
    Messner, SJ
    Meschino, WS
    Piron, CA
    Narod, SA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (11): : 1317 - 1325
  • [58] Systematic review: Using magnetic resonance imaging to screen women at high risk for breast cancer
    Warner, Ellen
    Messersmith, Hans
    Causer, Petrina
    Eisen, Andrea
    Shumak, Rene
    Plewes, Donald
    [J]. ANNALS OF INTERNAL MEDICINE, 2008, 148 (09) : 671 - 679
  • [59] Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy?
    Warren, RML
    Bobrow, LG
    Earl, HM
    Britton, PD
    Gopalan, D
    Purushotham, AD
    Wishart, GC
    Benson, JR
    Hollingworth, W
    [J]. BRITISH JOURNAL OF CANCER, 2004, 90 (07) : 1349 - 1360
  • [60] Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer
    Yeh, E
    Slanetz, P
    Kopans, DB
    Rafferty, E
    Georgian-Smith, D
    Moy, L
    Halpern, E
    Moore, R
    Kuter, I
    Taghian, A
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2005, 184 (03) : 868 - 877